PATENT REGISTER | |||||||||||||||||||||||||||||||||||||||||
A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 1997/012 1999/002 2010/016 | |||||||||||||||||||||||||||||||||||||||||
Status | Expired | Patent No. | 71155 | ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Application No. | 1991/0548 | Date of Filing | 18/02/1991 | ||||||||||||||||||||||||||||||||||||||
Sealing Date | 07/01/1997 | Application Published | 19/08/1991 | ||||||||||||||||||||||||||||||||||||||
Title of Invention | Acyl compounds | ||||||||||||||||||||||||||||||||||||||||
Priority |
|
||||||||||||||||||||||||||||||||||||||||
Inventors |
Peter Buhlmayer Franz Ostermayer Tibur Schmidlin |
||||||||||||||||||||||||||||||||||||||||
Patent Granted to |
CIBA-GEIGY AG Klybeckstrasse 141 CH-4002 Basel SWITZERLAND |
||||||||||||||||||||||||||||||||||||||||
Current Proprietor |
NOVARTIS AG Lichtstrasse 35 4002 Basel SWITZERLAND |
||||||||||||||||||||||||||||||||||||||||
Address for service |
FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 IRELAND |
||||||||||||||||||||||||||||||||||||||||
Renewal Fees |
|
||||||||||||||||||||||||||||||||||||||||
10/07/1997 | Request for grant of a Supplementary Protection Certificate, citing Patent number 71155 as the relevent basic patent, in respect of the product Valsartan or a pharmaceutically acceptable salt or ester thereof filed on 26 JUN 1997. Reference number of request is SPC970012. | ||||||||||||||||||||||||||||||||||||||||
27/01/1998 | NOVARTIS AG, a Swiss Company, of Schwarzwaldallee 215, 4058 Basel, Switzerland, recorded as proprietor by virtue of Certificate of Merger dated 20 DEC 1996. See file no. 70519 for Certificate of Merger. | ||||||||||||||||||||||||||||||||||||||||
14/01/1999 | Supplementary Protection Certificate Number SPC 12/97, having an expiry date of 12 May 2011, granted on 14 January 1999. | ||||||||||||||||||||||||||||||||||||||||
08/03/1999 | Request for grant of a Supplementary Protection Certificate, citing Patent number 71155 as the relevent basic patent, in respect of the product Valsartan or a pharmaceutically acceptable salt or ester thereof in combination with hydrochlorothiazide filed on 26 FEB 1999. Reference number of request is SPC990002. | ||||||||||||||||||||||||||||||||||||||||
13/03/2006 | Request for grant of Supplementary Protection Certificate No. 1999/002 rejected in respect of Article 10(2) of Council Regulation (EEC) No. 1768/92. [Journal No. 2043, 05/04/2006] | ||||||||||||||||||||||||||||||||||||||||
20/12/2007 | Appeal by Novartis against the rejection of Supplementary Protection Certificate application dismissed by the High Court. | ||||||||||||||||||||||||||||||||||||||||
23/04/2008 | Change of address of proprietor from NOVARTIS AG, an Aktiengesellschaft organised and existing under the laws of Switzerland, Schwarzwaldallee 215, 4058 Basel, CH to NOVARTIS AG, Lichtstrasse 35, 4002 Basel, CH recorded on 22/04/2008. | ||||||||||||||||||||||||||||||||||||||||
25/04/2008 | By virtue of a Licence dated 18/04/2008, Novartis Ireland Limited, Beach House, Beach Hill Office Campus, Clonskeagh, Dublin 4, IE, have been registered as exclusive licensee. Certified copy of Licence on File No. 71155. | ||||||||||||||||||||||||||||||||||||||||
29/04/2010 | Request for grant a Supplementary Protection Certificate, citing Patent number 71155 as the relevant basic patent, in respect of the product Valsartan, amlodipine and hydrochlorithiazide and pharmaceutically acceptable salt thereof filed on 14/04/2010. Reference number of request is 2010/016. | ||||||||||||||||||||||||||||||||||||||||
01/11/2010 | Application for an extension of the duration of Supplementary Protection Certificate No. 1997/012 filed on 24 September 2010. | ||||||||||||||||||||||||||||||||||||||||
30/11/2010 | Application for an extension of the duration of Supplementary Protection Certificate No. 1997/012 granted on 22/12/2010. New expiry date of Supplementary Protection Certificate, as extended, is 12/11/2011. [JRNL 2166] | ||||||||||||||||||||||||||||||||||||||||
01/03/2011 | Patent expired on 17/02/2011. | ||||||||||||||||||||||||||||||||||||||||
13/03/2012 | Request for grant of Supplementary Protection Certificate No. 2010/016 withdrawn on 13/03/2012. [Journal No. 2200, 11/04/2012] |